Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Experimental Animals|March 6, 2023
The past and present of therapeutic strategy for Alzheimer's diseases: potential for stem cell therapyMasanori A MurayamaExperimental Animals|June 30, 2024
Complement C3 deficient mice show more severe imiquimod-induced psoriasiform dermatitis than wild-type mice regardless of the commensal microbiotaMasanori A MurayamaFrontiers in Immunology|March 2, 2023
Chemokines and chemokine receptors as promising targets in rheumatoid arthritisMasanori A Murayama, Jun Shimizu, Chie Miyabe, et al.Frontiers in Immunology|March 11, 2024
Streptococcal infection and autoimmune diseasesAyaka Ohashi, Masanori A Murayama, Yoshishige Miyabe, et al.Experimental Animals|August 7, 2024
Clodronate liposome treatment contributes to the nerve regeneration in corneal nerve involvement of diabetic miceHiroki Ueno, Takaaki Hattori, Hsi-Hua Chi, et al.Frontiers in Immunology|December 20, 2021
The CTRP3-AdipoR2 Axis Regulates the Development of Experimental Autoimmune Encephalomyelitis by Suppressing Th17 Cell DifferentiationMasanori A Murayama, Hsi-Hua Chi, Mako Matsuoka, et al.Current Medicinal Chemistry|July 19, 2013
Free fatty acids-sensing G protein-coupled receptors in drug targeting and therapeuticsTomo Yonezawa, Riho Kurata, Kaori Yoshida, et al.Frontiers in Medicine|July 12, 2023
Innate immune responses in Behçet disease and relapsing polychondritisJun Shimizu, Masanori A Murayama, Yoshihisa Mizukami, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 17, 2014
Excess IL-1 signaling enhances the development of Th17 cells by downregulating TGF-β-induced Foxp3 expressionSatoshi Ikeda, Shinobu Saijo, Masanori A Murayama, et al.Plos One|January 27, 2022
Nicotine treatment regulates PD-L1 and PD-L2 expression via inhibition of Akt pathway in HER2-type breast cancer cellsMasanori A Murayama, Erika Takada, Kenji Takai, et al.Pageof 3